Vista Pharmaceuticals Ltd.

11.40 +0.43 ▲3.9%

28 March 2024, 04:01:00 PM
Volume: 53,228

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vistapharmaceuticals.com
Market Cap 50.70 Cr.
Enterprise Value(EV) 59.96 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -1.78 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.54 Trailing Twelve Months Ending 2023-12
Book Value / Share 8.35 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.28 Calculated using Price: 10.66
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 4.76 Cr. 47,564,899 Shares
FaceValue 2
About Vista Pharmaceuticals Ltd.
Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America.

Vista Pharmaceuticals Ltd. Delivery

Delivered Qty
Traded Qty

Vista Pharmaceuticals Ltd. Performance

1 Day
+3.92%
1 Week
-4.20%
1 Month
-20.0%
3 Month
-26.12%
6 Month
-37.36%
1 Year
+30.43%
2 Year
+21.02%
5 Year
-41.84%
10 Year
+245.45%

Vista Pharmaceuticals Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 13.94 7.15 8.97 10.19 3.15 -11.68 -6.43 -2.6 -17.16
Return on Capital Employed (%) 14.16 9.57 8.92 12.42 6.28 -5.2 -5.1 -3.75 -9.85
Return on Assets (%) 7.39 3.15 3.7 4.67 1.78 -7.11 -3.89 -1.7 -10.73

Vista Pharmaceuticals Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 10 11 17 32 36 30 33 35 37 39
Non Curr. Liab. 0 8 5 6 6 5 11 4 3 2
Curr. Liab. 12 7 19 15 11 16 9 13 14 14
Minority Int.
Equity & Liab. 23 26 41 53 53 51 53 52 53 54
Non Curr. Assets 11 10 16 25 29 30 37 29 30 30
Curr. Assets 12 16 26 28 23 21 15 24 24 24
Misc. Exp. not W/O
Total Assets 23 26 41 53 53 51 53 52 53 54

Vista Pharmaceuticals Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 14 15 24 29 31 23 1 0 1 8
Other Income 0 0 0 0 3 4 0 0 0 1
Total Income 14 15 24 29 34 27 1 1 1 9
Total Expenditure -11 -13 -21 -24 -30 -28 -3 -2 -5 -13
PBIDT 3 3 3 6 4 -1 -2 -1 -4 -5
Interest 0 -1 -1 -2 -2 -2 -2 -1 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -2
Taxation 0 0 0 -1 0 0 2 2 0 -1
Exceptional Items
PAT 1 1 1 2 1 -4 -2 -1 -6 -8
Adjusted EPS 1 0 0 1 0 -1 -1 0 -2 -2

Vista Pharmaceuticals Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 -4 -3 3 -5 3 1 -7 -1 -2
Cash Fr. Inv. 0 0 0 -4 -11 -6 -2 0 0 -1
Cash Fr. Finan. 4 3 6 11 1 0 7 1 3
Net Change 0 0 5 -4 -1 -1 0 0 0
Cash & Cash Eqvt 0 0 0 6 2 1 0 0 0 0

Vista Pharmaceuticals Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 36.94 35.44 35.44 35.44 35.44 35.44 30.51 29.51 27.81
Public 63.06 64.56 64.56 64.56 64.56 64.56 69.49 70.49 72.19
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Vista Pharmaceuticals Ltd. Announcements

Fri, 29 Mar 2024
Closure of Trading Window
Closure of Trading Window
Tue, 13 Feb 2024
Outcome Of Circular Resolutions Passed By Board Of Directors Of The Company By Circulation On 13.02.2024 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
Circular resolution
Sat, 10 Feb 2024
Outcome Of Board Meeting Under Regulation 30 Read With 33 (3) (C) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Board Meeting Outcome

Vista Pharmaceuticals Ltd. Technical Scans

Thu, 28 Mar 2024
High Delivery Percentage High Delivery Percentage
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Below Last Week Low Close Below Last Week Low

Vista Pharmaceuticals Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 388,812.23 1,620.50 +0.8%
Cipla Ltd. 120,673.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 102,679.14 6,171.85 +2.0%
Zydus Lifesciences Ltd. 101,151.67 1,007.35 +0.8%
Mankind Pharma Ltd. 92,029.19 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. 91,330.58 6,347.35 +1.9%
Divi's Laboratories Ltd. 91,234.91 3,452.55 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.66 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 32.54 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.64 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 34.01 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 53.29 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.71 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 65.97 3,452.55 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.23 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.66 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.82 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.37 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 10.36 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.52 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 7.00 3,452.55 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,452.55 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,452.55 +2.6%

Vista Pharmaceuticals Ltd. FAQ's

What is Vista Pharma share price?

Can I buy Vista Pharma shares now?

What is the Market Cap of Vista Pharma?

What are the key metrics to analyse Vista Pharma?

What is the 52 Week High and Low of Vista Pharma?

What is the trend of Vista Pharma share price?